The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

Multiple myeloma (MM) is a plasma cell malignancy comprising 10% of hematologic cancers, associated with bone marrow dysfunction and organ damage. High-risk cytogenetic MM patients, identified by specific genetic abnormalities, face poor outcomes despite recent advancements. Traditional treatments o...

Celý popis

Podrobná bibliografie

Vydáno v:	Frontiers in medicine Ročník 12; s. 1575914
Hlavní autoři:	Zhou, Huixing, Chen, Wenming
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 13.05.2025
Témata:	CD38 antibodies high-risk cytogenetics Medicine minimal residual disease multiple myeloma novel drug regimens progression-free survival multiple myeloma novel drug regimens progression-free survival CD38 antibodies meta-analysis minimal residual disease systematic review high-risk cytogenetics
ISSN:	2296-858X, 2296-858X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!